Human pancreatic beta-like cells converted from fibroblasts

Nature Communications

Volumn 7, Issue , 2016, Pages

  Zhu, Saiyong ^a   Russ, Holger A ^b   Wang, Xiaojing ^a   Zhang, Mingliang ^a   Ma, Tianhua ^a   Xu, Tao ^a   Tang, Shibing ^a   Hebrok, Matthias ^b   Ding, Sheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; CHEMICAL COMPOUND; GROWTH FACTOR; GLUCOSE; INSULIN;

CELLS AND CELL COMPONENTS; DIABETES; GLUCOSE; HORMONE; MEDICAL GEOGRAPHY; MEDICINE; PROTEIN; SECRETION;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL TRANSDIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIABETES MELLITUS; FIBROBLAST; FOREGUT; GENOMIC INSTABILITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS ISLET BETA CELL; STEM CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WNT SIGNALING PATHWAY; ANIMAL; CELL CULTURE TECHNIQUE; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

MUS;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLASTS; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; STEM CELLS;

EID: 84954477944     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10080     Document Type: Article

References (70)

1. D'Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392-1401 (2006).
2. Zhang, D. et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19, 429-438 (2009).
3. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008).
4. Rezania, A. et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61, 2016-2029 (2012).
5. Szot, G. L. et al. Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm. Cell Stem Cell 16, 148-157 (2015).
6. Russ, H. A. et al. Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J. 34, 1759-1772 (2015).
7. Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121-1133 (2014).
8. Pagliuca, F. W. et al. Generation of functional human pancreatic beta cells in vitro. Cell 159, 428-439 (2014).
9. Chen, S. et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5, 258-265 (2009).
10. Guo, T., Landsman, L., Li, N., Hebrok, M. Factors expressed by murine embryonic pancreatic mesenchyme enhance generation of insulin-producing cells from hESCs. Diabetes 62, 1581-1592 (2013).
11. Nostro, M. C. et al. Stage-specific signalling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 138, 861-871 (2011).
12. Sakano, D. et al. VMAT2 identified as a regulator of late-stage beta-cell differentiation. Nat. Chem. Biol. 10, 141-148 (2014).
13. Nostro,M. C. et al. Efficient generation of NKX6-1\+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Rep. 4, 591-604 (2015).
14. Cheng, X. et al. Self-renewing endodermal progenitor lines generated from human pluripotent stem cells. Cell Stem Cell 10, 371-384 (2012).
15. Sneddon, J. B., Borowiak, M., Melton, D. A. Self-renewal of embryonic-stemcell-derived progenitors by organ-matched mesenchyme. Nature 491, 765-768 (2012).
16. Kelly, O. G. et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 29, 750-756 (2011).
17. Kim, J., Ambasudhan, R., Ding, S. Direct lineage reprogramming to neural cells. Curr. Opin. Neurobiol. 22, 778-784 (2012).
18. Sancho-Martinez, I., Baek, S. H., Izpisua Belmonte, J. C. Lineage conversion methodologies meet the reprogramming toolbox. Nat. Cell. Biol. 14, 892-899 (2012).
19. Xu, J., Du, Y., Deng, H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell 16, 119-134 (2015).
20. Li, W., Li, K., Wei, W., Ding, S. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 13, 270-283 (2013).
21. Zhu, S., Wang, H., Ding, S. Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signalling-directed lineage conversion. Nat. Protoc. 10, 959-973 (2015).
22. Efe, J. A. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell. Biol. 13, 215-222 (2011).
23. Wang, H. et al. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Rep. 6, 951-960 (2014).
24. Kim, J. et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl Acad. Sci. USA 108, 7838-7843 (2011).
25. Zhu, S. et al. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res. 24, 126-129 (2014).
26. Lee, J. H. et al. Single transcription factor conversion of human blood fate to NPCs with CNS and PNS developmental capacity. Cell Rep. 11, 1367-1376 (2015).
27. Kurian, L. et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nat. Methods 10, 77-83 (2013).
28. Li, J. et al. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler. Thromb. Vasc. Biol. 33, 1366-1375 (2013).
29. Zhu, S. et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 508, 93-97 (2014).
30. Li, K. et al. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell 14, 228-236 (2014).
31. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409-412 (2011).
32. Stainier, D. Y. A glimpse into the molecular entrails of endoderm formation. Genes Dev. 16, 893-907 (2002).
33. Tian, T., Meng, A. M. Nodal signals pattern vertebrate embryos. Cell. Mol. Life. Sci. 63, 672-685 (2006).
34. D'Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541 (2005).
35. Zhu, S. et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651-655 (2010).
36. Oliver-Krasinski, J. M., Stoffers, D. A. On the origin of the beta cell. Genes Dev. 22, 1998-2021 (2008).
37. Spence, J. R. et al. Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev. Cell 17, 62-74 (2009).
38. Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299-312 (2015).
39. Hentze, H. et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. 2, 198-210 (2009).
40. Kunisada, Y., Tsubooka-Yamazoe, N., Shoji, M., Hosoya, M. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res. 8, 274-284 (2012).
41. Seymour, P. A., Sander, M. Historical perspective: beginnings of the beta-cell: current perspectives in beta-cell development. Diabetes 60, 364-376 (2011).
42. Pan, F. C., Wright, C. Pancreas organogenesis: from bud to plexus to gland. Dev. Dyn. 240, 530-565 (2011).
43. Henseleit, K. D. et al. NKX6 transcription factor activity is required for alphaand beta-cell development in the pancreas. Development 132, 3139-3149 (2005).
44. Borowiak, M. et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4, 348-358 (2009).
45. Zhu, S., Wei, W., Ding, S. Chemical strategies for stem cell biology and regenerative medicine. Annu. Rev. Biomed. Eng. 13, 73-90 (2011).
46. Nostro, M. C., Keller, G. Generation of beta cells from human pluripotent stem cells: potential for regenerative medicine. Semin Cell Dev. Biol. 23, 701-710 (2012).
47. Sasai, Y. Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell 12, 520-530 (2013).
48. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632 (2008).
49. Lee, J. et al. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife 2, e00940 (2013).
50. Li, W. et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife 3, e01846 (2014).
51. Li, W. et al. Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells. Nat. Biotechnol. 32, 1223-1230 (2014).
52. Polo, J. M. et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617-1632 (2012).
53. Soufi, A., Donahue, G., Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004 (2012).
54. Soufi, A. et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015).
55. Kao, D. I. et al. Endothelial cells control pancreatic cell fate at defined stages through EGFL7 signalling. Stem Cell Rep. 4, 181-189 (2015).
56. Oshimori, N., Fuchs, E. The harmonies played by TGF-beta in stem cell biology. Cell Stem Cell 11, 751-764 (2012).
57. Shih, H. P. et al. A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 139, 2488-2499 (2012).
58. Gu, G., Dubauskaite, J., Melton, D. A. Direct evidence for the pancreatic lineage: NGN3\+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447-2457 (2002).
59. Wang, T. et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9, 575-587 (2011).
60. Esteban, M. A. et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79 (2010).
61. Stadtfeld, M. et al. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat. Genet. 44, 398-405, S391-392 (2012).
62. Blaschke, K. et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500, 222-226 (2013).
63. Xie, R. et al. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 12, 224-237 (2013).
64. Russ, H. A., Hebrok, M. Taming the young and restless-epigenetic gene regulation in pancreas and beta-cell precursors. EMBO J. 33, 2135-2136 (2014).
65. Xu, C. R. et al. Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification. EMBO J. 33, 2157-2170 (2014).
66. Goodyer, W. R. et al. Neonatal beta cell development in mice and humans is regulated by calcineurin/NFAT. Dev. Cell 23, 21-34 (2012).
67. Taylor, B. L., Liu, F. F., Sander, M. Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep. 4, 1262-1275 (2013).
68. Wang, P. et al. A high-throughput chemical screen reveals that harminemediated inhibition of DYRK1A increases human pancreatic beta Cell Rep.lication. Nat. Med. 21, 383-388 (2015).
69. Russ, H. A. et al. Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS One 6, e25566 (2011).
70. Bar-Nur, O., Russ, H. A., Efrat, S., Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9, 17-23 (2011).